Literature DB >> 24842662

New thermoresistant polymorph from CO2 recrystallization of minocycline hydrochloride.

Miguel A Rodrigues1, João M Tiago, Luis Padrela, Henrique A Matos, Teresa G Nunes, Lídia Pinheiro, António J Almeida, Edmundo Gomes de Azevedo.   

Abstract

PURPOSE: To prepare and thoroughly characterize a new polymorph of the broad-spectrum antibiotic minocycline from its hydrochloride dehydrate salts.
METHODS: The new minocycline hydrochloride polymorph was prepared by means of the antisolvent effect caused by carbon dioxide. Minocycline recrystallized as a red crystalline hydrochloride salt, starting from solutions or suspensions containing CO2 and ethanol under defined conditions of temperature, pressure and composition.
RESULTS: This novel polymorph (β-minocycline) revealed characteristic PXRD and FTIR patterns and a high melting point (of 247 ºC) compared to the initial minocycline hydrochloride hydrates (α-minocycline). Upon dissolution the new polymorph showed full anti-microbial activity. Solid-state NMR and DSC studies evidenced the higher chemical stability and crystalline homogeneity of β-minocycline compared to the commercial chlorohydrate powders. Molecular structures of both minocyclines present relevant differences as shown by multinuclear solid-state NMR.
CONCLUSIONS: This work describes a new crystalline structure of minocycline and evidences the ability of ethanol-CO2 system in removing water molecules from the crystalline structure of this API, at modest pressure, temperature and relatively short time (2 h), while controlling the crystal habit. This process has therefore the potential to become a consistent alternative towards the control of the solid form of APIs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842662     DOI: 10.1007/s11095-014-1406-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  The salt-cocrystal continuum: the influence of crystal structure on ionization state.

Authors:  Scott L Childs; G Patrick Stahly; Aeri Park
Journal:  Mol Pharm       Date:  2007-04-27       Impact factor: 4.939

2.  Probing hydrogen bonding in cocrystals and amorphous dispersions using (14)N-(1)H HMQC solid-state NMR.

Authors:  Andrew S Tatton; Tran N Pham; Frederick G Vogt; Dinu Iuga; Andrew J Edwards; Steven P Brown
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

3.  Powder crystallography of pharmaceutical materials by combined crystal structure prediction and solid-state 1H NMR spectroscopy.

Authors:  Maria Baias; Cory M Widdifield; Jean-Nicolas Dumez; Hugh P G Thompson; Timothy G Cooper; Elodie Salager; Sirena Bassil; Robin S Stein; Anne Lesage; Graeme M Day; Lyndon Emsley
Journal:  Phys Chem Chem Phys       Date:  2013-03-18       Impact factor: 3.676

Review 4.  Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.

Authors:  E Fuller Torrey; John M Davis
Journal:  Clin Schizophr Relat Psychoses       Date:  2012-01

5.  Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide.

Authors:  R Bettini; L Bonassi; V Castoro; A Rossi; L Zema; A Gazzaniga; F Giordano
Journal:  Eur J Pharm Sci       Date:  2001-06       Impact factor: 4.384

6.  Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.

Authors:  Vanthida Huang; Chrissy M Cheung; Glenn W Kaatz; Michael J Rybak
Journal:  Int J Antimicrob Agents       Date:  2009-11-08       Impact factor: 5.283

7.  Didanosine polymorphism in a supercritical antisolvent process.

Authors:  R Bettini; R Menabeni; R Tozzi; M B Pranzo; I Pasquali; M R Chierotti; R Gobetto; L Pellegrino
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

8.  Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.

Authors:  Luis Padrela; Miguel A Rodrigues; Sitaram P Velaga; Henrique A Matos; Edmundo Gomes de Azevedo
Journal:  Eur J Pharm Sci       Date:  2009-05-27       Impact factor: 4.384

9.  Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.

Authors:  Baskar Mannargudi; David McNally; William Reynolds; Jack Uetrecht
Journal:  Drug Metab Dispos       Date:  2009-06-08       Impact factor: 3.922

10.  Pharmaceutical Cocrystals and Their Physicochemical Properties.

Authors:  Nate Schultheiss; Ann Newman
Journal:  Cryst Growth Des       Date:  2009-04-20       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.